Drug Shortage Report for INTRON A

Last updated on 2017-07-15 History
Report ID 8757
Drug Identification Number 02223406
Brand name INTRON A
Common or Proper name interferon alfa-2b lyophilized powder
Company Name MERCK CANADA INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) WATER INTERFERON ALFA-2B
Strength(s) 1ML 10000000UNIT
Dosage form(s) LIQUID POWDER FOR SOLUTION
Route of administration INTRALESIONAL INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Packaging size 1X10 MIU
ATC code L03AB
ATC description IMMUNOSTIMULANTS
Reason for shortage Demand increase for the drug.
Anticipated start date 2017-05-03
Actual start date 2017-05-03
Estimated end date 2017-07-21
Actual end date 2017-07-14
Shortage status Resolved
Updated date 2017-07-15
Company comments Limited quantities will be available
Health Canada comments
Tier 3 Status No
Contact Address 16750 ROUTE TRANSCANADIENNE
KIRKLAND, QUEBEC
CANADA H9H 4M7
Company contact information 1-800-567-2594 medinfocanada@merck.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v17 2017-07-15 English Compare
v16 2017-07-14 French Compare
v15 2017-07-14 English Compare
v14 2017-07-12 English Compare
v13 2017-07-11 English Compare
v12 2017-06-10 English Compare
v11 2017-06-09 French Compare
v10 2017-06-09 English Compare
v9 2017-06-05 French Compare
v8 2017-06-05 English Compare
v7 2017-05-08 French Compare
v6 2017-05-08 English Compare
v5 2017-05-04 French Compare
v4 2017-05-03 French Compare
v3 2017-05-03 English Compare
v2 2017-05-03 French Compare
v1 2017-05-03 English Compare

Showing 1 to 17 of 17